Lung :: FDA stops marketing of unapproved timed-release guaifenesin drug products

The U.S. Food and Drug Administration (FDA) today announced its intention to take action against companies that market unapproved drug products in timed-release dosage form that contain guaifenesin, a substance commonly used in medicines to relieve cough and cold symptoms by stimulating removal of mucous from the lungs.

Asthma :: Asthmatx completes enrollment in pivotal study of bronchial thermoplasty

Asthmatx, Inc., a medical device company that has developed a catheter-based procedure for the treatment of asthma, announced today the successful completion of enrollment in its pivotal FDA approved IDE study, the Asthma Intervention Research 2 (AIR2) Trial of the Alair? Bronchial Thermoplasty System. Bronchial Thermoplasty is a non-drug treatment for asthma under clinical investigation in the United States.

Pollution :: Doctors should assess and advise on risks of outdoor air pollution

If you have some form of lung or cardiovascular disease, has your doctor told you how to check today’s “AQI”?and what to do if it’s over 100? Health care professionals should inform sensitive patients about the risks of exposure to air pollutants and recommend avoidance strategies for days when air quality is low, according to a special report in The American Journal of the Medical Sciences, published by the Southern Society for Clinical Investigation by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack